ICU Medical Holds 2026 Outlook as Third-Quarter Revenue Rises
Photo: TokenPost
ICU Medical maintained its 2026 adjusted profit outlook after third-quarter revenue rose and net income turned positive, with the company expecting full-year results toward the upper ends of its guidance ranges. On Thursday, Nov. 5, ICU Medical reaffirmed its adjusted EBITDA outlook of $415 million to $435 million and its adjusted diluted earnings-per-share range of $8.60 to $9.00. The company expects results toward the higher end of both ranges but did not give a specific point forecast. On Aug.
Source: TokenPost
